Home » Topics » Conferences

Conferences
RSS

ONO-4641 shows safety and tolerability in phase I trial in MS

Oct. 21, 2010

Subanalyses of CLARITY data support benefits of cladribine tablets

Oct. 21, 2010

Zealand Pharma's ZP-2307 shows bone anabolic activity in vivo

Oct. 21, 2010

New antibiotics for multidrug-resistant pathogens in preclinical/clinical evaluation

Oct. 21, 2010

Ocrelizumab reduces disease activity in phase II trial in relapsing-remitting MS

Oct. 20, 2010

DepoVax-based vaccination leads to tumor regression in vivo

Oct. 20, 2010

HIV vaccine ALVAC vCP1521 is safe in infants given birth to by HIV-infected women

Oct. 20, 2010

Snapshots: Studies of new antibiotic CB-182804

Oct. 20, 2010

Cancer vaccine CDX-1401 safe and active in ongoing phase I/II trial

Oct. 20, 2010

Levetiracetam does not improve cerebellar symptoms of multiple sclerosis

Oct. 19, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...